Timber Pharmaceuticals Inc (NYSE American:TMBR)

Delayed Data
As of Oct 30
 -0.04 / -3.96%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Timber Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +1,137.11% increase from the last price of 0.97.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Timber Pharmaceuticals Inc. This rating has held steady since January, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Dec 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 55.88%
Growthannually 53.14%


Growthquarterly --
Growthannually -100.00%
Key to the earnings and sales forecast charts.